Target intelligence / Profile preview

Salmonella enterica serovar Enteritidis outer membrane antigen

Molecular classification
Outer membrane protein, Lipopolysaccharide, Bacterial antigen, Other
01

Overview

Salmonella enterica serovar Enteritidis outer membrane antigens are a collection of surface-associated molecules, principally outer membrane proteins (such as OmpA, OmpD, FliD, PgtE) and lipopolysaccharide (LPS) O-antigen, that form the interface between the bacterium and host environment[2][3][4][6][7]. These antigens are essential for bacterial survival, virulence, and immune evasion, mediating functions like structural integrity of the bacterial cell, adhesion to host cells, and resistance to the host immune response, particularly complement-mediated killing. Outer membrane antigens, notably OMPs and OAg, are prime candidates for vaccine development and are under investigation as biomarkers for infection and as immunogens capable of eliciting protective immunity[4][7]. The antigenic variability across different strains poses a challenge to broadly protective interventions, but these outer membrane antigens remain primary targets for antibacterial immunity, diagnostics, and vaccine strategies. Key proteins and features: - OmpA: Structural and immunogenic, involved in host immune recognition[3]. - OmpD: Important for antibody access and vaccine-induced protection, but OmpD-O-antigen interactions limit cross-serovar efficacy[7]. - PgtE: Outer membrane protease that degrades complement components, conferring serum resistance and enhancing survival in host tissues[2][3]. - FliD: Flagellar hook-associated protein, implicated in adhesion and immunogenicity[3]. - Lipopolysaccharide (LPS) O-antigen: Defines serovar, acts as a key surface antigen and barrier, varies among serovars (O:9 antigen in S. Enteritidis)[4][7]. Vaccine candidates, such as GMMA (Generalized Modules for Membrane Antigens), utilize these native outer membrane antigens to stimulate broad and functional immune responses[4]. LPS and protein antigens are also being actively investigated as immunodiagnostics and research biomarkers for infection with this pathogen.

Other names
Salmonella Enteritidis outer membrane antigenS. Enteritidis OMPsS. Enteritidis outer membrane proteinsS. Enteritidis surface antigens
02

Mechanism of action

Induction of opsonophagocytosis and complement-mediated killing via antibody recognition; Prevention of complement activation (e.g., PgtE-mediated cleavage of complement proteins); Promotion of immune responses through antigen presentation

03

Biological functions

Immune evasionAdhesionStructural integrityPathogenesis/virulenceImmune response stimulationOther
04

Disease associations

InfectionImmune escapeVaccine targetOther
05

Safety considerations

Antigenic variation among OMPs and LPS structure can limit cross-protective vaccine efficacyPotential for immune-mediated tissue damage if overactivation occursLPS can induce strong inflammatory responses (endotoxin shock risk)
06

Interacting drugs

Antibodies (monoclonal)

2 more in the full profile.

07

Biomarkers

Antibodies against specific OMPs (such as OmpA, FliD, PgtE)LPS O-antigen (O:9 serogroup for S. Enteritidis)

Beyond the preview

Go deeper on Salmonella enterica serovar Enteritidis outer membrane antigen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salmonella enterica serovar Enteritidis outer membrane antigen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call